Hundreds of pharmacies are permanently closing their doors as consumer trends change and businesses succumb to financial pressures. 

The FDA has added a boxed warning to the labeling of Veozah, a medication used to treat hot flashes, highlighting a rare but serious risk of liver injury. 

Pharmacy benefit managers were paid by drugmakers, including Purdue Pharma, to keep opioid prescriptions flowing even as overdose deaths soared across the U.S., according to an investigation by The New York Times. 

An uptake of GLP-1 medications is coinciding with an increase in first-time diagnoses after 15 days of taking a GLP-1, according to findings from Truveta Research and Reuters. 

The FDA has granted fast track designation to two combination vaccine candidates that aim to protect adults 50 and older from both influenza and COVID-19, according to a Dec. 16 AJMC report. 

Shares of the three largest pharmacy benefit managers' parent companies took a hit Dec. 16, after President-elect Donald Trump vowed that his administration would work to "knock out the middlemen."

The rise of telehealth services offering weight loss drugs like Ozempic has sparked concern among health professionals, with experts warning that these easy-to-access treatments are exacerbating eating disorders, Bloomberg reported Dec. 16. 

Centralized medication access (CMA) is revolutionizing the patient journey to specialty care. We consistently see the challenges that arise from the lack of medication access and believe that a centralized medication access team is the solution. It allows the clinical…

In March, MultiCare Health System joined Mark Cuban Cost Plus Drug Co.'s Marketplace and accessed 125 generics at a discounted price. Between April and October, the partnership saved MultiCare $1 million. 

Sanofi filed a lawsuit against the Health Resources and Services Administration in federal court Dec. 16, challenging the agency's decision to potentially remove the company from the 340B Drug Pricing Program over the company's proposed credit model.